Loading clinical trials...
Loading clinical trials...
The main goal of this study is to investigate the tolerability to the use of the GRAIL system in subjects affected by Rett syndrome, particularly referred to: 1. Grail environment (training in dark conditions, interaction with wide and surrounding screen, positioning over the treadmill); 2. time to prepare a set of body marker in order to execute a gait analysis; 3. walking activity over treadmill, with immersive virtual reality; 4. proprioceptive stimulatione provided by the GRAIL platform; 5. cognitive-attentive span time to the activity proposed. The secondary goal is to understand if a training that avail of treadmill and virtual reality would be useful in the future in improving gait characteristics in subjects affected by Rett syndrome
Age
6 - 35 years
Sex
FEMALE
Healthy Volunteers
No
IRCCS E. Medea
Bosisio Parini, Lecco, Italy
Start Date
July 1, 2021
Primary Completion Date
March 22, 2022
Completion Date
April 15, 2022
Last Updated
January 20, 2023
9
ACTUAL participants
GRAIL
DEVICE
Lead Sponsor
IRCCS Eugenio Medea
Collaborators
NCT06338267
NCT06856759
NCT04463316
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions